NCT01139359View on ClinicalTrials.gov

Safety Study of Darinaparsin in Combination With Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) to Treat Lymphoma

PHASE1WithdrawnINTERVENTIONAL

Timeline

Start Date

June 30, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Lymphoma

Interventions

DRUG

darinaparsin

I.V. darinaparsin given in a dose escalation manner, once a day for 5 days per cycle.

DRUG

CHOP

Cyclophosphamide 750 mg/m2 IV Day 8 of each Cycle; Doxorubicin 50 mg/m2 IV Day 8 of each Cycle; Vincristine 1.4 mg/m2 IV Day 8 of each Cycle; Prednisone 100 mg oral Days 8-12 of each Cycle.